Leo Laboratories Limited

Longwick Road, Princes Risborough, Bucks., HP27 9RR
Telephone: +44 (0)1844 347 333
Fax: +44 (0)1844 276 385
Medical Information e-mail: medical-info.uk@leo-pharma.com

Patient Information Leaflet last updated on the eMC: 17/11/2010
PIL Dovonex Scalp Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change due to user-testing of patient information
Updated on 03/09/2008 and displayed until 17/11/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/06/2007 and displayed until 03/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/01/2007 and displayed until 07/06/2007
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 16/01/2003 and displayed until 08/01/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 12/02/2001 and displayed until 16/01/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 01/08/2000 and displayed until 12/02/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   calcipotriol